References
- Başak AN. The molecular pathology of β-thalassemia in Turkey: The Bogaziçi University experience. Hemoglobin. 2007;31(2):233–241
- Weatherall DJ. Hemoglobinopathies worldwide: Present and future. Curr Mol Med. 2008;8(7):592–599
- Patrinos GP, Giardine B, Riemer C, et al. Improvements in the HbVar database of human hemoglobin variants and thalassemia mutations for populations and sequence variation studies. Nucleic Acids Res. 2004;32(6):537–541
- Beksac MS, Gümrük F, Gürgey A, et al. Prenatal diagnosis of hemoglobinopathies in Hacettepe University. Pediatr Hematol Oncol. 2011;28(1):51–55
- Tadmouri GO, Başak AN. β-Thalassemia in Turkey: A review of the clinical, epidemiological, molecular, and evolutionary aspects. Hemoglobin. 2001;25(2):227–239
- Olivieri NF. The β-thalassemias. N Eng J Med. 1999;341(2):99–109
- Altay Ç. The frequency and distribution pattern of β-thalassemia mutations in Turkey. Turkish J Hematol. 2002;19(2):309–315
- Altay Ç. Abnormal hemoglobins in Turkey. Turkish J Hematol. 2002;19(1):63–74
- Cürük MA, Arpaci A, Atilla G, et al. Genetic heterogeneity of β thalassemia at Çukurova in southern Turkey. Hemoglobin. 2001;25(2):241–245
- Ropero P, González FA, Cela E, et al. Association in cis of the mutations +20 (C>T) in the 5′ untranslated region and IVS-II-745 (C>G) on the β-globin gene. Hemoglobin. 2013;37(2):112–118
- Guvenc B, Canataroglu C, Unsal SM, et al. β-Thalassemia mutations and hemoglobinopathies in Adana, Turkey: Results from a single center study. Arch Med Sci. 2012;8(3):411–414
- Bennani C, Tamouza R, Rouabhi F, et al. The spectrum of thalassaemia in Algeria: Possible origins of the molecular heterogeneity and a tentative diagnostic strategy. Br J Haematol. 1993;84(2):335–337
- Kyriacou K, Al Quobaili F, Pavlou E, et al. Molecular characterization of β-thalassemia in Syria. Hemoglobin. 2000;24(1):1–13
- Al-Allawi NA, Jubrael JM, Hughson M. Molecular characterization of β-thalassemia in the Dohuk region of Iraq. Hemoglobin. 2006;30(4):479–486
- Waye JS, Borys S, Eng B, et al. Spectrum of β-thalassemia mutations in Egypt. Hemoglobin. 1999;23(3):255–261
- Chouk I, Daoud BB, Mellouli F, et al. Contribution to the description of the β-thalassemia spectrum in Tunisia and the origin of mutation diversity. Hemoglobin. 2004;28(3):189–195
- Zahed L, Qatanani M, Nabulsi M, Taher A. β Thalassemia mutations and haplotype analysis in Lebanon. Hemoglobin. 2000;24(4):269–276
- Maragoudaki E, Vrettou C, Kanavakis E, et al. Molecular, haematological and clinical studies of a silent β-gene C → G mutation at 6 bp 3′ to the termination codon (+1480 C→G) in twelve Greek families. Br J Haematol. 1998;103(1):45–51
- Schilirò G, Mirabile E, Testa R, et al. Presence of hemoglobin-opathies in Sicily: A historic perspective. Am J Med Genet. 1997;69(2):200–206
- Rosatelli MC, Dozy A, Faa V, et al. Molecular characterization of β thalassemia in the Sardinian population. Am J Hum Genet. 1992;50(2):422–426
- Villegas A, Ropero P, Gonzalez FA, et al. The thalassemia syndromes: Molecular characterization in the Spanish population. Hemoglobin. 2001;25(3):273–283
- Cao A, Goosens M, Pirastu M. β-Thalassaemia mutation in Mediterranean populations. Br J Haematol. 1989;71(3):309–312